Enanta Pharmaceuticals (ENTA) Other financing activities (2012 - 2026)
Enanta Pharmaceuticals' Other financing activities came in at $305,000 for fiscal Q2 2026 (quarter ended Mar 31, 2026), up 140.2% from $127,000 a year earlier and up 214.4% from the prior quarter.
Enanta Pharmaceuticals (ENTA) Other financing activities (2012 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Other financing activities was $277,000, down 5.8% from FY2024.
- Other financing activities carries a five-year compound annual growth rate of -28.7% (FY2020 to FY2025).
- Going back by fiscal year, Other financing activities was $294,000 in FY2024 (-99.9%), $200 million in FY2023, $1.23 million in FY2022 (+130.1%) and $534,000 in FY2021 (-64.4%).
- The fiscal Q2 2026 figure represents the highest quarterly Other financing activities since fiscal Q3 2023.
- Year-over-year, Other financing activities increased in two of the last five quarters, with growth averaging 15.3%.
- The fastest year-over-year change in Other financing activities over five years came in fiscal Q2 2023 (growth of 545.0%), and the weakest in fiscal Q2 2024 (a decline of 96.8%).
- Business Quant data shows ENTA's Other financing activities at $97,000 (Q1 2026), $10,000 (Q4 2025) and $3,000 (Q3 2025) in the three fiscal quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.19 Bn | 1,101.77 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.03 Bn | 534.56 Bn | 17.26 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn |
| 4 | Merck | 366.82 Bn | 321.20 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.82 Bn | 261.81 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn |
| 7 | Amgen | 235.89 Bn | 191.29 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.64 Bn | 164.84 Bn | 6.22 Bn |
| 9 | Pfizer | 169.32 Bn | 115.96 Bn | 10.94 Bn |
| 10 | Enanta Pharmaceuticals | 335.99 Mn | -392.00 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -305,000.00 |
| Dec 31, 2025 | -97,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | -127,000.00 |
| Dec 31, 2024 | -137,000.00 |
| Sep 30, 2024 | -19,000.00 |
| Mar 31, 2024 | -92,000.00 |
| Dec 31, 2023 | -183,000.00 |
| Sep 30, 2023 | -23,000.00 |
| Jun 30, 2023 | 199.68 Mn |
| Mar 31, 2023 | -2.91 Mn |
| Dec 31, 2022 | -825,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Mar 31, 2022 | -451,000.00 |
| Dec 31, 2021 | -777,000.00 |
| Dec 31, 2020 | -534,000.00 |
| Mar 31, 2020 | -358,000.00 |
| Dec 31, 2019 | -1.14 Mn |
| Sep 30, 2018 | 1,000.00 |
Enanta Pharmaceuticals Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ENTA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();